New models to predict survival of patients with difficult ventilator-weaning diagnosed with community-acquired pneumonia

用于预测社区获得性肺炎且呼吸机撤机困难患者生存率的新模型

阅读:3

Abstract

BACKGROUND: High mortality is common in mechanically ventilated patients with severe community-acquired pneumonia (CAP). This study sought to create prediction models and determine factors for the pneumonia patients under difficult ventilator weaning in a respiratory care center. METHODS: In total, 353 CAP and hospital-acquired pneumonia (HAP) patients admitted to a respiratory care center (RCC) from January 1, 2015 to December 31, 2017 were included in this retrospective cohort study. Mortality and weaning risks factors were collected and analyzed for validating the prediction models. The study focuses primarily on CAP patients, with HAP data used to external validation. RESULTS: Among 270 CAP patients in model testing and validation, CURB-65 (Confusion, Uremia, Respiratory rate, Blood pressure, aged ≥65 years) and CUB-65 similarly predicted RCC survival (AUROCs ~65%). Three new RCC survival prediction models incorporated age ≥65, hypotension, BUN >19 mg/dl, ventilator type (replacing respiratory rate), and GCS ≤ 8 (replacing confusion), and either white blood cells (WBCs) or hemoglobin (Hb) were additionally included in model 1 or model 2. In CAP test samples, AUROCs with CAP test sample were 77.51% (model 1), 75.99% (model 2), and 77.97% (model 3). All three new models showed higher AUROCs than CURB-65, with significantly improved predictability in models 1 (p = 0.0354) and 3 (p = 0.0383). All three models demonstrated satisfactory performance (AUROC ≥ 80%) for predicting RCC survival in the CAP validation sample. CONCLUSIONS: These new models more accurately predicted survival during RCC admission. Furthermore, they offer clinicians a better predictive tool for survival in CAP patients facing difficult ventilator weaning.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。